Next Article in Journal
A Review of the Impact of Maternal Obesity on the Cognitive Function and Mental Health of the Offspring
Next Article in Special Issue
Qualitative and Quantitative Assessment of Vascular Changes in Diabetic Macular Edema after Dexamethasone Implant Using Optical Coherence Tomography Angiography
Previous Article in Journal
Synthesis and Characterization of Dual-Sensitive Fluorescent Nanogels for Enhancing Drug Delivery and Tracking Intracellular Drug Delivery
Previous Article in Special Issue
Effects of Ranibizumab and Aflibercept on Human Müller Cells and Photoreceptors under Stress Conditions
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Autophagy Regulates Proteasome Inhibitor-Induced Pigmentation in Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells

1
Faculty of Medicine and Life Sciences, BioMediTech, University of Tampere, 33014 Tampere, Finland
2
Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland, 70211 Kuopio, Finland
3
School of Pharmacy, University of Eastern Finland, 70211 Kuopio, Finland
4
SIBS Labs, University of Eastern Finland, 70211 Kuopio, Finland
5
Department of Ophthalmology, University of Tampere, SILK, TAUH Eye Center, Tampere University Hospital, 33014 Tampere, Finland
6
The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
7
Department of Ophthalmology, Kuopio University Hospital, 70029 Kuopio, Finland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(5), 1089; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051089
Submission received: 17 January 2017 / Revised: 11 May 2017 / Accepted: 12 May 2017 / Published: 19 May 2017
(This article belongs to the Special Issue Retinal Diseases: Bridging Basic and Clinical Research)

Abstract

:
The impairment of autophagic and proteasomal cleansing together with changes in pigmentation has been documented in retinal pigment epithelial (RPE) cell degeneration. However, the function and co-operation of these mechanisms in melanosome-containing RPE cells is still unclear. We show that inhibition of proteasomal degradation with MG-132 or autophagy with bafilomycin A1 increased the accumulation of premelanosomes and autophagic structures in human embryonic stem cell (hESC)-derived RPE cells. Consequently, upregulation of the autophagy marker p62 (also known as sequestosome-1, SQSTM1) was confirmed in Western blot and perinuclear staining. Interestingly, cells treated with the adenosine monophosphatedependent protein kinase activator, AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide), decreased the proteasome inhibitor-induced accumulation of premelanosomes, increased the amount of autophagosomes and eradicated the protein expression of p62 and LC3 (microtubule-associated protein 1A/1B-light chain 3). These results revealed that autophagic machinery is functional in hESC-RPE cells and may regulate cellular pigmentation with proteasomes.

1. Introduction

The retinal pigment epithelial (RPE) cells, which are situated between the photoreceptor cells and choroid in the back of the eye, are vitally important for vision by maintaining the viability of photoreceptor cells [1]. Central characteristics of RPE cell degeneration associated with aging include subtle changes in pigmentation, as well as accumulation of intracellular lipofuscin, a highly cross-linked aggregate of oxidized proteins, and extracellular drusen deposits. Accumulation of toxic lipofuscin and drusen in aged RPE cells is suggested to occur as a result of disturbed proteasomal or lysosomal degradation systems, including autophagy [2,3,4,5].
Autophagy is essential for maintaining healthy cell homeostasis: the autophagic process begins with the formation of isolation membranes known as phagophores [6], which then become elongated and form mature double membrane autophagosomes. These autophagosomes engulf portions of cytoplasm containing oligomeric protein complexes and organelles, fuse with lysosomes, and their content is then degraded by lysosomal enzymes. Daily phagocytosis of engulfed photoreceptor outer segments (POS) and their degradation in lysosomes (heterophagy) by RPE are critical for maintaining visual functions [7,8]. However, the POS-derived A2E (N-retinylidene-N-retinylethanolamine) and oxidatively-damaged proteins accumulate and impair acidification of the lysosome, weakening its degradation capacity [9,10,11] and lysosomal enzyme activity [12,13]. Failure of autophagy in aged post-mitotic cells, including RPE cells, can result in accumulation of lipofuscin, which in turn can further diminish lysosomal enzyme activity [9,14] and lead to cellular degeneration and finally to cell death [2,5]. A decline in autophagy is usually accompanied by the accumulation of aggregates expressing autophagy markers p62 (also known as sequestosome-1, SQSTM1) and LC3 (microtubule-associated protein 1A/1B-light chain 3, also known as MAP1LC3A), normally degraded by lysosomal enzymes in autophagic processes [3,5,15].
RPE cell pigmentation mainly results from melanosomal melanin [16], which acts as a scavenger of reactive oxygen species (ROS) and chelator of metals, thereby protecting neural retina from oxidative damage [16,17,18]. During aging, as a result of increased oxidative stress and decreased melanin content, the antioxidant capacity is estimated to decline in the retina [19,20,21]. Moreover, increased melanosomal oxygen consumption and ROS production have been observed in aged RPE cells. This in turn is estimated to occur due to melanosomal lipofuscin accumulation onto the surface of melanosomes in RPE cells [22,23,24]. Previously, it was believed that lipofuscin aggregates could not be degraded by proteasomal or lysosomal enzymes, nor transported into the extracellular space via exocytosis [25]. However, there are indications that RPE cell melanolipofuscin might be exocytozed and degraded by macrophages or complexed with β-cyclodextrins and removed [26,27]. Furthermore, recent findings have revealed that both proteasomes and autophagy takes part in the regulation of cellular pigmentation [28,29,30,31].
RPE-like cells, expressing genes and proteins corresponding to the human RPE [32,33,34], have been successfully differentiated from human embryonic stem cells (hESCs) and human-induced pluripotent stem cells (hiPSCs) [32,35,36]. In addition, highly pigmented hESC-RPE and hiPSC-RPE cells exhibit functions that are characteristic to native RPE cells: they are able to phagocytose POS, secrete RPE trophic factors such as pigment epithelium-derived factor and form a tight epithelium with high electrical resistance [32,33,34,37,38,39,40]. However, the functionality of autophagic and proteolytic machinery in the regulation of melanocytic pigmentation in hESC-RPE cells is yet to be determined. In this study, co-operation of proteasome and autophagy machinery in the regulation of melanocytic pigmentation in mature hESC-RPE cells was assessed.

2. Results

2.1. Human Embryonic Stem Cells-Derived Retinal Pigment Epithelial Cells Show the Typical Retinal Pigment Epithelial Phenotype and Express Retinal Pigment Epithelial Specific Genes

In this study, our aim was to assess the functionality of mature hESC-RPE cells; therefore, it was important to verify that the used hESC-RPE cells have been successfully differentiated and matured from pluripotent stem cells. This was done by assessing gene expression with Reverse Transcription-Polymerase Chain Reaction (RT-PCR), protein expression and localization with immunofluorescence labelling, confocal microscopy and evaluating cell morphology and pigmentation with brightfield phase contrast microscopy and Transmission Electron Microscopy (TEM). Reverse Transcription-Polymerase Chain Reaction gene expression analysis revealed that hESC-RPE cells did not express the Oct3/4 marker of pluripotency and only a minute amount of eye specific lineage marker PAX6. All of the analyzed RPE-specific genes, namely MITF, Bestrophin and RPE65, were expressed by hESC-RPE cells (Figure 1a). The gene expression pattern was similar in mature hESC-RPE Regea08/017 cells compared to the human RPE cells (Figure S1). In addition, hESC-RPE cells were polarized as seen in the vertical confocal sections demonstrating protein expression of CRALBP (green, cellular retinaldehyde-binding protein) and bestrophin (red) (Figure 1b). In the brightfield micrograph (Figure 1c), it can be seen that the hESC-RPE cells had acquired cobblestone morphology and a high degree of pigmentation, which is characteristic for mature RPE cells. The polarization of hESC-RPE cells, localization of apical tight junctions and brush border, high order of organization of extracellular matrix and the localization of pigmented granules are visible in low resolution TEM (Figure 1d). The partial intermingling of CRALBP and bestrophin label indicates that hESC-RPE cells had not reached the status of full maturation.

2.2. Proteasomes and Autophagy Regulate Amount of Melanosomes

The treatments and doses utilized in this work were chosen due to their known and validated actions on autophagic machinery. Proteasome inhibition, e.g., with MG-132, has been shown to activate autophagy [2,3,5,41]. AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide), an analogue of adenosine monophosphate (AMP), can stimulate AMP-dependent protein kinase (AMPK) activity, inhibit mechanistic target of rapamycin (mTor) and then induce autophagy [3,42,43,44,45,46,47]. Bafilomycin A1 is an inhibitor of vacuolar type H+-ATPase, and while preventing the acidification of lysosomes, it also inhibits fusion of lysosomes with autophagosomes and formation of autolysosomes [42,43]. The effects of MG-132, AICAR, bafilomycin A1, MG-132 + AICAR or MG-132 + bafilomycin A1 for 24 h on the number and maturation of melanosomes and autophagosomes within hESC-RPE cells were visualized with TEM. Proteasome inhibition with MG-132 evoked accumulation of both premelanosomes and autophagosomes (p < 0.01; Figure 2). Autophagy inducer AICAR heavily increased the amount of autophagosomes, but decreased the number of premelanosomes during proteasome inhibition (MG-132 vs. AICAR + MG-132, p < 0.01). As expected, bafilomycin A1 treatment strongly increased the number of autophagosomes (Figure 2a,d,e). AICAR treatment did not show significant changes in the number of melanosomes, premelanosomes or autophagic vesicles. Thus, AICAR seems to accelerate autophagic process during proteasome inhibition. In addition, we observed that bafilomycin A1 rather than AICAR increased the number of melanosomes under proteasome inhibition (p < 0.05; Figure 2a,c).
Melanin has a broad absorbance spectrum, which can be used for melanin quantitation [48]. In addition to microscopic evaluation of pigmentation in cells, melanin pigment levels were also quantitated from cell lysates by using absorbance spectroscopy at 690 nm. In accordance with the microscopy, the absorbance spectrum of MG-132-treated samples displayed increased melanin levels compared to control samples (Figure 2e), and it was even more pronounced together with bafilomycin A1. However, when the cells were exposed to MG-132 together with AICAR, a moderate change in melanin levels was observed. Note that the amount of melanin is in line with the number of melanosomes in different treatments, but statistical significance was not observed possibly due to the limited sample size (n = 2).

2.3. 5-Aminoimidazole-4-carboxamide Ribonucleotide Decreases Amount of Microtubule-Associated Protein 1A/1B-Light Chain 3 and Sequestosome-1 during Proteasome Inhibition

The functionality of the autophagic machinery was examined by assessing the amount of autophagy marker proteins p62, LC3-II and the ratio of LC3–II/I in Western blots of whole cell extracts. Conversion of the cytosolic form of LC3-I to the membrane-bound phosphatidylethanolamine (PE) lipidated LC3-II form indicates autophagic activity [49]. The p62 protein is usually found in protein aggregates with polyubiquitinated proteins, and when autophagosomal function is inhibited, the amount of p62 is usually increased [2,3,5]. The turnover, which is the degradation rate of LC3-II within autolysosomes, can be quantified when analyzing the amount of LC3-II after treatments [5]. The ratio of LC3-II/I was highest when cells were treated with a combination of proteasome inhibitor MG-132 and autophagy inhibitor bafilomycin A1 for 24 h (Figure 3a and Figure S6). MG-132 treatment slightly increased the level of LC3-II, but because the level of LC3-I was also increased by the treatment, the resulting LC3 ratio was similar to the control. AICAR treatment together with MG-132 decreased the level of LC3-II indicating activated autophagy (Figure 3b). Proteasome inhibition with MG-132 evoked an intensive accumulation of p62 (Figure 3c and Figures S2 and S7). In line with LC3 data, the combination treatment with MG-132 and AICAR abolished expression of p62 when compared to pure MG-132 treatment. Since p62 co-localizes with LC3 and AICAR enhances autophagy, it is reasonable to assume that increased autophagy has led to decreased levels of both p62 and LC3-II through increased degradation [5].

2.4. 5-Aminoimidazole-4-carboxamide Ribonucleotide Treatment Induces Autophagy Flux with Proteasome Inhibition

The fluorescently-tagged fusion proteins, green fluorescent protein (GFP)-mCherry-LC3A, pEGFP-LC3 and pDsRed2-hp62 plasmids (p), were analyzed with confocal microscopy after treatment with MG-132, AICAR, bafilomycin A1 alone or in combination. This pH-sensitive GFP-mCherry-LC3A vector emits green and red (yellow) fluorescence when at neutral pH (e.g., autophagosome), but emits only red fluorescence in acidic compartments (e.g., autolysosomes) because the fluorescence of GFP is quenched by the low pH. Cells transfected with GFP-mCherry-LC3A and treated with MG-132 showed induced formation of strongly red positive aggregates (Figure 3d), which is clearly visible also in the output image (Figure 3e) and histogram (Figure 3f). This is evidence that MG-132 induces the formation of acidic autolysosomes. The combination treatment with MG-132 and autophagy inducer AICAR evoked an intensive red color staining after a 3-h treatment (Figure 3e,f), which was obliterated after 24 h (Figure 3e,f), indicating effective autophagy flux. Green or yellow fluorescence was more prominent after treatment with AICAR, bafilomycin A1, AICAR + bafilomycin A1 or MG-132 + bafilomycin A1 and especially after MG-132 + AICAR, indicating the formation of autophagosomes, but not autolysosomes. GFP-mCherry-LC3A transfected cells exhibited noticeably less red color after AICAR + bafilomycin A1 treatment compared to MG-132 + AICAR treatment. Therefore, the combination treatment with AICAR + bafilomycin A1 was not considered to be an important control in further analyses used in this work.
The second transfections with both pEGFP-LC3 and pDsRed2-hp62 resulted in faint cytoplasmic fluorescence, observed using confocal microscopy, indicating that transfection of hESC-RPE cells was successful (Figure S3). The MG-132 treatment induced the formation of small pEGFP-LC3 and pDsRed2-hp62-positive aggregates. Meanwhile, formation of aggregates was not observed after the combination treatment with MG-132 and autophagy inducer AICAR. Incubation with bafilomycin A1 evoked increased double staining of the pEGFP-LC3 and pDsRed2-hp62 constructs (Figure S3).

2.5. Proteasome Inhibition and Bafilomycin A1 Induces Melanogenesis

The lightness of microscopic images has been previously shown to be an objective and quantitative method to evaluate the degree of RPE cell pigmentation [47]. Therefore, we acquired five phase contrast brightfield images with identical light exposure and illumination settings from randomly selected areas in all cell culture inserts and evaluated the darkness from each image. This pigmentation analysis indicates that exposure to MG-132 reduces the lightness of hESC-RPE cells (Figure S4). The changes were statistically significant compared to control after MG-132 treatment (p < 0.001) and similarly after MG-132 + bafilomycin A1 (p = 0.002) treatment. MG-132 significantly (p < 0.001) increased pigmentation also when comparing bafilomycin A1 and MG-132 + bafilomycin A1 treated samples. Finally, the decrease of pigmentation after AICAR treatment (MG-132 vs. MG-132 + AICAR) was highly significant (p < 0.001).
It is essential to verify that the used chemical treatments do not decrease cell viability or increase cell death. Here, it was assessed with a commercial viability assay. Microscopic observation revealed that the chemical treatments used in these experimental procedures altered the relative intensity of calcein-AM fluorescence compared to control: fluorescence was decreased in MG-132-treated samples, but increased in MG-132 + AICAR- and AICAR-treated samples (Figure 4). It should be noted that calcein fluorescence intensity is dependent both on cell viability and the amount of pigmentation. Higher fluorescence in MG-132 + AICAR and AICAR treatments reveals both increased autophagy and decreased pigmentation, while lower fluorescence in MG-132, MG-132 + bafilomycin A1 and bafilomycin A1 is associated with the melanosome number and melanogenesis (Figure 2a,c). There were no statistically-significant differences in the number of dead cells between treated samples and control (Figure 4).

3. Discussion

One of the most central characteristics of RPE cell phenotype is melanin pigmentation in lysosome-related organelles, called melanosomes [16]. Melanin eliminates ROS and acts as a chelator of metals, thus protecting young RPE cells [16,17,18]. However, cytoprotective effects are gradually lost during aging, leading to decreased antioxidant capacity and also vice versa to increased oxidative stress [19,20,21,22,23]. Melanosome differentiation and cellular pigmentation are controlled by proteins whose turnover is regulated by proteasomes [50,51,52,53]. Watabe et al. reported that tyrosinase activity and melanosome production are regulated by whether the protein is retained in the endoplasmic reticulum to be degraded by proteasomes or transported through Golgi and endosomes to premelanosomes [50]. The transport from endoplasmic reticulum is influenced by organelle pH. Proteasome inhibition has been shown to affect lysosomal degradation and endosomal sorting of membrane proteins to lysosomes [54,55]. Thus, exposing cells to MG-132 and bafilomycin A1 can be anticipated to regulate tyrosinase processing, trafficking and melanogenesis [49]. Inhibition of proteasomes may result in reduced proteasomal degradation of tyrosinase and therefore increased levels of tyrosinase and premelanosomes as observed in the present study. Previous findings indicate that also autophagy takes part in the regulation of cellular pigmentation [28,29,30,31].
Autophagic processes have been assessed previously using the immortalized ARPE-19 RPE cell line [3,5,49]. Nonetheless, hESC-RPE cells differ from ARPE-19 cells in their gene expression [35] and pigmentation [56], as well as aggregation levels under proteasome inhibition [2,3,5]. In this study, we show that proteasome inhibition leads to high accumulation of melanosomes in hESC-RPE cells, a finding in line with previous documentations [28,52,53,57]. The lower calcein fluorescence intensity detected in live/dead viability assay is in line with the accumulation of melanosomes in MG-132- and MG-132 + bafilomycin A1-treated samples. This may be cellular compensatory mechanism to provide cytoprotection via melanin [18,28,52,53]. Functional autophagy can be interpreted as a beneficial effect for preventing RPE degeneration [49,58,59]. Cleansing of lipofuscin loaded melanosomes in autophagy may be anticipated to decrease oxidative stress in aged RPE cells [22,23,26]. In young RPE cells, many other cytoprotective systems, such as antioxidant production, melanogenesis, molecular chaperone response, balanced proteolysis and DNA damage response may compensate autophagy [18,25,48,60,61,62,63]. Autophagy regulating proteins have also been shown to accelerate melanogenesis that support beneficial dual role of autophagy in the regulation of melanosome turnover [31]. Autophagy provides selective clearance and participation in exocytosis [64], but its role in clearance of lipofuscin loaded melanosomes is not known.
In this study, our observations revealed that autophagy cleanses melanosomes under proteasome inhibition. This was also seen here as increased calcein fluorescence in the live/dead assay. Moreover, inhibition of the basal autophagosome flux level by bafilomycin A1 induced melanogenesis in hESC-RPE cells, suggesting crosstalk of proteasomes and autophagosomes in the regulation of pigmentation in this cell type. When the autophagic process is impaired in ARPE-19 cells, they develop strong perinuclear aggregation, but weak pigmentation [3,5]. In contrast, hESC-RPE cells indicated high pigmentation levels, but a relatively weak protein aggregation. In line with our recent publications [3,5], the autophagy receptor p62 also accumulated in response to proteasome inhibition in hESC-RPE cells. However, inhibition of the autophagosome-lysosome fusion with bafilomycin A1 did not increase the level of p62 in mature hESC-RPE cells, as has been previously shown in ARPE-19 cells [5]. Formerly, autophagy clearance was revealed by using ARPE-19 cells in which the amount of perinuclear protein aggregates of p62 and LC3-II was downregulated during proteasome inhibition and AICAR exposure [5]. In this study, Western blot analysis exhibited an upregulation of p62 during proteasome inhibition that was alleviated when combined with AICAR treatment. Moreover, autophagy flux was confirmed with confocal microscopy by using a GFP-mCherry-LC3A vector.

4. Materials and Methods

4.1. Cell Culture and Treatments

The pluripotent hESC line Regea08/017 was derived and characterized in our laboratory at the University of Tampere, Finland, as described previously [39]. The hESC line was derived and cultured on top of mitotically inactivated (either γ-irradiated, 40 Gy or mitomycin C (10 μg/ mL, Sigma-Aldrich, St. Louis, MO, USA) treated) human foreskin fibroblast feeder cells (CRL-2429TM, ATCC, Manassas, VA, USA). The hESCs were cultured at 37 °C and 5% CO2 with hESC culture medium consisting of Knock-out Dulbecco’s Modified Eagle Medium (KO-DMEM) supplemented with 20% Knock-Out Serum Replacement (KO-SR), 2 mM Glutamax-I, 0.1 mM 2-mercaptoethanol (all from Life Technologies, Carlsbad, CA, USA), 1% non-essential amino acids (NEAA), 50 U/mL penicillin/streptomycin (both from Lonza Group Ltd., Basel, Switzerland) and 8 ng/mL human basic fibroblast growth factor (bFGF) (Peprotech, London, UK). The culture medium was replenished 5× a week, and undifferentiated colonies were manually passaged onto new feeder cells once a week.
Undifferentiated hESCs were induced to differentiate into RPE cells in floating cell aggregates by lowering the KO-SR concentration to 15% and removing bFGF, as previously described [34]. Floating aggregates were cultured for 76–140 days. The culture medium was replenished 3× a week. The pigmented areas of floating aggregates were manually dissected, dissociated with 1× trypsin-EDTA (ethylenediaminetetraacetic acid) and replated on collagen IV from human placenta (5 μg/cm2; Sigma-Aldrich) for enrichment of cell number.
After 108–322 days of culture, the pigmented areas were enzymatically dissociated with 1× trypsin-EDTA and seeded at a density of 100,000 cells/cm2 either on 24-well plates (BD Biosciences, San Jose, CA, USA) or PET cell culture inserts (Millipore Corporate, Billerica, MA, USA) coated with collagen IV (Sigma-Aldrich, St. Louis, MO, USA). The cells were further cultured for 80–194 days (a total of 158–356 days of culture). According to our standard procedure, the cultures were used for experiments when they have reached transepithelial electrical resistance (TEER) above 100 Ω·cm2, but preferentially over 200 Ω·cm2. The cell culture periods and number of replicates are presented in Table 1 and passage numbers and culture periods of independent experiments in Table S1.
Mature hESC-RPE cells were treated with 1 μM MG-132 (Calbiochem, San Diego, CA, USA), 2 mM AICAR (AICA ribonucleotide, 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside, Toronto Research Chemical, North York, ON, Canada, A611700), 50 nM bafilomycin A1 (Sigma-Aldrich) alone or in combination: 1 μM MG-132 + 50 nM bafilomycin A1 and 1 µM MG-132 + 2 mM AICAR (Figure S8). The control cells were treated with cell culture medium with the KO-SR of 15%, as described earlier. All treatments were carried out for 3 h and/or 24 h at 37 °C and 5% CO2.

4.2. Immunofluorescence Labelling

Adherent cells were subjected to immunofluorescence (IF) staining to detect the localization of RPE cell specific proteins as previously described [26]. Briefly, the cells were washed 3 × 5 min with PBS, fixed 10 min with 4% paraformaldehyde (pH 7.4; Sigma-Aldrich), washed with PBS, permeabilized in 0.1% Triton X-100/PBS (Sigma-Aldrich) for 10 min and washed 3× with PBS. Non-specific binding sites were blocked with 3% BSA (Sigma-Aldrich) in PBS for 1 h. Primary antibody incubations (Table 2) were carried out in 0.5% bovine serum albumin (BSA)-PBS for 1 h. Thereafter, cells were washed 3× with PBS. Secondary antibody incubations (Table 2) were carried out in 0.5% BSA-PBS for 1 h. Cells were washed 3× with PBS. Nuclei were counterstained with DAPI in VectaShield mounting medium (Vector Laboratories Inc., Burlingame, CA, USA). The entire labelling procedure was performed at room temperature (RT). Brightfield images were obtained with Zeiss AxioScope A1 phase contrast microscope with 63× magnification (Carl Zeiss, Jena, Germany). Confocal microscopy images were obtained with an LSM 700 confocal microscope (Carl Zeiss, Jena, Germany) using a 63× oil immersion objective. Overlays and image processing of confocal images were done in ZEN-software (Carl Zeiss). The negative control cells were cultured, stained and visualized similarly as actual immunofluorescence samples, except that the primary antibodies were omitted. Used antibodies are presented in Table 2.

4.3. RNA Extraction, Complementary DNA Synthesis and Reverse Transcription-Polymerase Chain Reaction

In order to analyze the gene expression of mature hESC-RPE cells, total RNA was extracted from hESC-RPE cells with a NucleoSpin XS-kit (Macherey-Nagel, GmbH & Co., Düren, Germany) according to the manufacturer’s instructions. The RNA concentration and its quality were assessed using NanoDrop 1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). RNA (40 ng) was reverse-transcribed to complementary DNA using MultiScribe Reverse Transcriptase (Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s instructions in the presence of an RNase inhibitor. Complementary DNA (cDNA) was used as a template in a PCR reaction, which was carried out using 5 U/μL Taq DNA Polymerase (Fermentas, Thermo Fisher Scientific Inc., Leicester, UK) with 5 μM specific primers (Biomers.net GmbH, Söflinger, Ulm, Germany, Table 3). The PCR reactions were carried out in PCR MasterCycler ep gradient (Eppendorf AG, Hamburg, Germany) as follows: 95 °C 3 min, 95 °C 30 s, annealing 30 s, 72 °C 1 min, 72 °C 5 min, for 38 cycles. Annealing temperatures and primer sequences are presented in Table 3 and Figure S1. PCR products were resolved in 2% agarose gels with a 50-base pair DNA ladder (MassRulerTM DNA Ladder Mix, Fermentas). The bands were visualized with the Quantity one 4.5.2. Basic program (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

4.4. Transmission Electron Microscopy

For transmission electron microscopic (TEM) examination, hESC-RPE cell samples were fixed with 2% glutaraldehyde (Electron Microscopy Sciences, Hatfield, PA, USA) prepared in 0.1 M phosphate buffer for 2 h at RT followed by incubation in 0.1 M phosphate buffer overnight at room temperature. Thereafter, the samples were post-fixed with 1% osmium tetroxide (Ladd Research, Williston, VT, USA) for 1 h at RT and dehydrated through a graded series of acetone (J. T. Baker, Avantor Performance Materials B.V., Deventer, The Netherlands): 70% acetone, 94% acetone and absolute acetone. The samples were then infiltrated in a 1:1 mixture of absolute acetone and epoxy resin (Ladd Research) for 1.5 h at RT, embedded in pure epoxy resin overnight at RT and polymerized for 48 h at 60 °C. Thin sections were stained with 1% uranyl acetate for 30 min and with 0.4% lead citrate (Fluka, Steinheim, Germany) for 5 min. Samples were examined and imaged with the JEM-2100F transmission electron microscope (TEM, JEOL Ltd., Tokyo, Japan). Identification of premelanosomes and melanosomes were done as shown previously [65].

4.5. Melanin Quantitation by Absorption Spectroscopy

Melanin pigment in the cell samples lysed in M-PER (Mammalian Protein Extraction Reagent) lysis buffer (see Section 4.6) was pelleted by centrifugation at 16,000× g for 17 min. After removal of supernatant, pigmented pellets were re-suspended in 100 µL of fresh M-PER buffer and absorbance was measured at 690 nm in clear 96-well plates by using EnVision multi-label reader (Perkin Elmer, Waltham, MA, USA). The RPE-choroid melanin isolated from porcine eyes was used as a standard [40].

4.6. Western Blot

The cell samples were washed with PBS (Lonza Group Ltd.), and cells were lysed in M-PER lysis buffer (Thermo Scientific, Waltham, MA, USA) according to the manufacturer’s instructions 24 h after adding the chemical treatments. Whole cell extracts (25–30 μg of protein) were run in 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) gels and thereafter wet-blotted to nitrocellulose membranes (Amersham, Pittsburgh, PA, USA). The blocking of membranes was done in 3% skimmed milk powder in 0.3% Tween-20/PBS at room temperature for 1.5 h. Thereafter, the membranes were incubated with mouse monoclonal p62 antibody (Cat. No. sc-28359; Santa Cruz Biotechnology Inc., CA, USA) diluted 1:1000 in 0.5% BSA in 0.3% Tween-20/PBS, rabbit polyclonal LC3 antibody (Cat. No. 3868; Cell Signaling, Danvers, MA, USA) diluted 1:1000 in 5% BSA in 0.1% Tween-20/TBS (Tris-buffered saline) overnight at 4 °C, or mouse monoclonal α-tubulin antibody (Cat. No. T5168, Sigma-Aldrich) diluted 1:8000 in 1% milk powder in 0.05% Tween-20/PBS for 1 h at RT. After washing 3× for 5 min with 0.3% Tween-20/PBS (p62 antibody), 0.1% Tween-20/TBS (LC3 antibody) or 0.05% Tween-20/PBS (alpha-Tubulin), the membranes were incubated for 2 h at RT (except for alpha-Tubulin, which was incubated for 1 h) with horseradish peroxidase-conjugated anti-rabbit IgG (Novex™, #A16014, Thermo Fisher Scientific, Rockford, IL, USA) or anti-mouse Imunoglobulin G (IgG) antibodies (GE Healthcare, Little Chalfont, UK). The secondary antibodies were diluted 1:10,000 in 3% skimmed milk powder in 0.3% Tween-20/PBS for p62, 3% skimmed milk powder in 0.1% Tween-20/TBS for LC3 and 1% skimmed milk in 0.05% Tween-20/PBS for α-tubulin. Before detection, all membranes were washed as described earlier. Protein–antibody complexes were detected with an enhanced chemiluminescent assay for horseradish peroxidase (Millipore, Billerica, MA, USA).

4.7. Confocal Microscopy Analysis

Mature hESC-RPE cells with a cobblestone morphology were transfected with a tandem fluorescently tagged LC3 (GFP-mCherry-LC3A), which at neutral pH fluoresces yellow in autophagosomes. Acidification quenches the GFP signal, thus only the red fluorescence of mCherry is detected in autolysosomes [8]. The transfection protocol is described previously [66]. Briefly, 250 μg of GFP-mCherry-LC3A were added to ExGen500 transfection reagent (Fermentas, Thermo Fisher Scientific Inc., Leicester, UK) following the manufacturer’s instructions. Transfection was continued for 24 h at 37 °C and 5% CO2. Thereafter, cells were exposed to MG-132, AICAR and/or bafilomycin A1 for 3 h or 24 h, then mounted in Vectashield with DAPI (H-1200) and placed on ice. Samples were examined immediately with LSM 700 confocal microscope 63× oil immersion similarly as described for immunofluorescence samples in Section 2.2. The amount of red, green and yellow of the confocal images was analyzed with Image J. The pixels of red channel were divided with the pixels of green channel, re-scaled from 0–2 (green equalized 0; yellow = 1 and red 2. The output was presented with UnionJack color scale (0 = black, white = 1 and red = 2) to enhance the visibility. In addition, the separation is shown in histograms. Additional transfections were performed with plasmids pEGFP-hLC3Am and pDsRed2-hp62 (Figure S3).

4.8. Cell Viability

The effects of 1 μM MG-132, 50 nM bafilomycin A1, 2 mM AICAR or their combination treatments on cell viability were assessed using Live/Dead Viability/Cytotoxity kit for mammalian cells (Invitrogen, Carlsbad, CA, USA). Briefly, 23.5 h after commencing the chemical treatments, the cells were rinsed with HEPES-buffered salt solution (HBSS, Lonza Group Ltd., Basel, Switzerland). Thereafter, cells were incubated for 30 min at 37 °C and 5% CO2 with a mixture of 0.25 µM calcein-AM (green fluorescence) and 0.5 µM Ethidium homodimer-1 (EthD-1, red fluorescence) diluted in HBSS, either in the presence or absence of chemicals. Cells were imaged under a fluorescence microscope (Olympus IX) to detect the viable (green fluorescence) and dead cells (red fluorescence) with a 20× long working distance objective. The same imaging acquisition settings were applied for all samples. The calcein-AM fluorescence intensity was quantified with Image J software from 5 separate 288 × 288 dpi areas (which contained 62–88 cells) from images of two separate experiments. The intensities were correlated to the untreated control. The number of dead cells (red fluorescence) was also calculated from 5 separate 288 × 288 dpi areas from images of two separate experiments.

4.9. Ethical Issues

BioMediTech at University of Tampere has the approval of the National Authority for Medicolegal Affairs Finland to study human embryos (Diary number1426/32/300/05), and a supportive statement of the Ethical Committee of the Pirkanmaa Hospital District to derive, culture and differentiate hESC lines from surplus human embryos (R05116). No new lines were derived for this study. All methodological details were carried out in accordance with the approved guidelines.

4.10. Statistical Analyses

The statistical significance of quantification of melanosomes, premelanosomes and autophagic vesicles, relative calcein-AM intensity and number of dead cells in the field of view and the degree of pigmentation analyzed from brightfield images were analyzed with PASW Statistics (Version 18, Quarry Bay, Hong Kong, China), using the two-tailed Mann–Whitney U test. The data from Western blot experiments were subjected to one-way analysis of variance (ANOVA), followed by Tukey’s test for multiple comparison (p-values < 0.05 were considered significant). The number of replicates in each experiment is indicated in the figure legends.

5. Conclusions

In this work, we showed how proteasomal inhibition increased the amount of highly pigmented melanosomal granules and the accumulation of p62 in hESC-RPE cells. Furthermore, the AMPK activator AICAR promoted cleansing of melanin granules, p62 and LC3-II during proteasome inhibition. These data indicate that autophagy machinery is functional in hESC-RPE cells and may have a role in the regulation of cellular pigmentation.

Supplementary Materials

Supplementary materials can be found at www.mdpi.com/1422-0067/18/5/1089/s1.

Acknowledgments

Outi Melin, Outi Heikkilä, Hanna Pekkanen, Anne Seppänen, Raija Hukkila and Hanna Hiidenmaa are thanked for technical assistance, Laura Pelkonen and Anna-Kaisa Rimpelä for the porcine RPE melanin. The expertise of Teemu Ihalainen from the University of Tampere BioMediTech imaging core was used in imaging analyses and Alexandra Mikhailova in proof-reading the manuscript. This work was supported by the Kuopio University Hospital (Kai Kaarniranta) (Grant Number 5503743), the Finnish Eye Foundation (Kai Kaarniranta), the Finnish Funding Agency for Technology and Innovation (Kai Kaarniranta, Heli Skottman), the Health Research Council of the Academy of Finland (Kai Kaarniranta, Heli Skottman, Kati Juuti-Uusitalo) (Grant Numbers 139567, 218050 and 137801), the Päivikki and Sakari Sohlberg Foundation (Kai Kaarniranta, Heli Skottman), the Eye and Tissue Bank Foundation (Kati Juuti-Uusitalo), the Evald and Hilda Nissi Foundation and the Finnish Cultural Foundation-North-Savo (Arto Koistinen).

Author Contributions

Kati Juuti-Uusitalo, Niko Kivinen, Johanna Viiri, Juha M. T. Hyttinen and Mika Reinisalo carried out experiments, Niko Kivinen, Arto Koistinen and Kai Kaarniranta analyzed the TEM data. Ali Koskela, Kati Juuti-Uusitalo, Debasish Sinha, Kai Kaarniranta analyzed the Western blot, confocal microscopy or calcein fluorescence data. Ali Koskela, Mika Reinisalo, Kati Juuti-Uusitalo, Debasish Sinha, Hannu Uusitalo, Heli Skottman and Kai Kaarniranta participated in scientific discussions and reviewed the manuscript.

Conflicts of Interest

The authors declare no conflict of interest. The founding sponsors had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; nor in the decision to publish the results.

References

  1. Strauss, O. The retinal pigment epithelium in visual function. Physiol. Rev. 2005, 85, 845–881. [Google Scholar] [CrossRef] [PubMed]
  2. Ryhänen, T.; Hyttinen, J.M.; Kopitz, J.; Rilla, K.; Kuusisto, E.; Mannermaa, E.; Viiri, J.; Holmberg, C.I.; Immonen, I.; Meri, S.; et al. Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J. Cell. Mol. Med. 2009, 13, 3616–3631. [Google Scholar] [CrossRef] [PubMed]
  3. Viiri, J.; Hyttinen, J.M.; Ryhänen, T.; Rilla, K.; Paimela, T.; Kuusisto, E.; Siitonen, A.; Urtti, A.; Salminen, A.; Kaarniranta, K. P62/sequestosome 1 as a regulator of proteasome inhibitor-induced autophagy in human retinal pigment epithelial cells. Mol. Vis. 2010, 16, 1399–1414. [Google Scholar] [PubMed]
  4. Höhn, A.; Jung, T.; Grimm, S.; Catalgol, B.; Weber, D.; Grune, T. Lipofuscin inhibits the proteasome by binding to surface motifs. Free Radic. Biol. Med. 2011, 50, 585–591. [Google Scholar] [CrossRef] [PubMed]
  5. Viiri, J.; Amadio, M.; Marchesi, N.; Hyttinen, J.M.; Kivinen, N.; Sironen, R.; Rilla, K.; Akhtar, S.; Provenzani, A.; D’Agostino, V.G.; et al. Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cells. PLoS ONE 2013, 8, e69563. [Google Scholar] [CrossRef] [PubMed]
  6. Parzych, K.R.; Klionsky, D.J. An overview of autophagy: Morphology, mechanism, and regulation. Antioxid. Redox Signal. 2014, 20, 460–473. [Google Scholar] [CrossRef] [PubMed]
  7. Kim, J.Y.; Zhao, H.; Martinez, J.; Doggett, T.A.; Kolesnikov, A.V.; Tang, P.H.; Ablonczy, Z.; Chan, C.C.; Zhou, Z.; Green, D.R.; et al. Noncanonical autophagy promotes the visual cycle. Cell 2013, 154, 365–376. [Google Scholar] [CrossRef] [PubMed]
  8. Valapala, M.; Wilson, C.; Hose, S.; Bhutto, I.A.; Grebe, R.; Dong, A.; Greenbaum, S.; Gu, L.; Sengupta, S.; Cano, M.; et al. Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/betaA3/A1-crystallin via V-ATPase-MTORC1 signaling. Autophagy 2014, 10, 480–496. [Google Scholar] [CrossRef] [PubMed]
  9. Holz, F.G.; Schütt, F.; Kopitz, J.; Eldred, G.E.; Kruse, F.E.; Völcker, H.E.; Cantz, M. Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Investig. Ophthalmol. Vis. Sci. 1999, 40, 737–743. [Google Scholar]
  10. Bergmann, M.; Schutt, F.; Holz, F.G.; Kopitz, J. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J. 2004, 18, 562–564. [Google Scholar] [CrossRef] [PubMed]
  11. Lakkaraju, A.; Finnemann, S.C.; Rodriquez-Boulan, E. The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells. Proc. Natl. Acad. Sci. USA 2007, 104, 11026–11031. [Google Scholar] [CrossRef] [PubMed]
  12. Kaemmerer, E.; Schutt, F.; Krohne, T.U.; Holz, F.G.; Kopitz, J. Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Investig. Ophthalmol. Vis. Sci. 2007, 48, 1342–1347. [Google Scholar] [CrossRef] [PubMed]
  13. Krohne, T.U.; Kaemmerer, E.; Holz, F.G.; Kopitz, J. Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action. Exp. Eye Res. 2010, 90, 261–266. [Google Scholar] [CrossRef] [PubMed]
  14. Finnemann, S.C.; Leung, L.W.; Rodriguez-Boulan, E. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc. Natl. Acad. Sci. USA 2002, 99, 842–847. [Google Scholar] [CrossRef] [PubMed]
  15. Wang, L.; Cano, M.; Handa, J.T. P62 provides dual cytoprotection against oxidative stress in the retinal pigment epithelium. Biochim. Biophys. Acta 2014, 1843, 1248–1258. [Google Scholar]
  16. Simon, J.D.; Hong, L.; Peles, D.N. Insights into melanosomes and melanin from some interesting spatial and temporal properties. J. Phys. Chem. B 2008, 112, 13201–13217. [Google Scholar] [CrossRef] [PubMed]
  17. Peters, S.; Lamah, T.; Kokkinou, D.; Bartz-Schmidt, K.U.; Schraermeyer, U. Melanin protects choroidal blood vessels against light toxicity. Z. Naturforsch. 2006, 61, 427–433. [Google Scholar] [CrossRef]
  18. Wang, Z.; Dillon, J.; Gaillard, E.R. Antioxidant properties of melanin in retinal pigment epithelial cells. Photochem. Photobiol. 2006, 82, 474–479. [Google Scholar] [CrossRef] [PubMed]
  19. Sarna, T.; Burke, J.M.; Korytowski, W.; Rόzanowska, M.; Skumatz, C.M.; Zareba, A.; Zareba, M. Loss of melanin from human RPE with aging: Possible role of melanin photooxidation. Exp. Eye Res. 2003, 76, 89–98. [Google Scholar] [CrossRef]
  20. Zareba, M.; Raciti, M.W.; Henry, M.M.; Sarna, T.; Burke, J.M. Oxidative stress in ARPE-19 cultures: Do melanosomes confer cytoprotection? Free Radic. Biol. Med. 2006, 40, 87–100. [Google Scholar] [CrossRef] [PubMed]
  21. Burke, J.M.; Henry, M.M.; Zareba, M.; Sarna, T. Photobleaching of melanosomes from retinal pigment epithelium: I. effects on protein oxidation. Photochem. Photobiol. 2007, 83, 920–924. [Google Scholar] [CrossRef] [PubMed]
  22. Rozankowski, B.; Burke, J.M.; Boulton, M.E.; Sarna, T.; Rozanowska, M. Human RPE melanosomes protect from photosensitized and iron-mediated oxidation but become pro-oxidant in the presence of iron upon photodegradation. Investig. Ophthalmol. Vis. Sci. 2008, 49, 2838–2847. [Google Scholar] [CrossRef] [PubMed]
  23. Biesemeier, A.; Yoeruek, E.; Eibl, O.; Schraermeyer, U. Iron accumulation in Bruch’s membrane and melanosomes of donor eyes with age-related macular degeneration. Exp. Eye Res. 2015, 137, 39–49. [Google Scholar] [CrossRef] [PubMed]
  24. Jung, T.; Bader, N.; Grune, T. Lipofuscin: Formation, distribution, and metabolic consequences. Ann. N. Y. Acad. Sci. 2007, 1119, 97–111. [Google Scholar] [CrossRef] [PubMed]
  25. Kaarniranta, K.; Hyttinen, J.; Ryhänen, T.; Viiri, J.; Paimela, T.; Toropainen, E.; Sorri, I.; Salminen, A. Mechanisms of protein aggregation in the retinal pigment epithelial cells. Front. Biosci. 2010, 2, 1374–1384. [Google Scholar] [CrossRef]
  26. Julien, S.; Schraermeyer, U. Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys. Neurobiol. Aging 2012, 33, 2390–2397. [Google Scholar] [CrossRef] [PubMed]
  27. Nociari, M.M.; Lehmann, G.L.; Perez Bay, A.E.; Rady, R.A.; Jiang, Z.; Goicochea, S.; Schreiner, R.; Warren, J.D.; Shan, J.; Adam de Beaumais, S.; et al. Beta cyclodextrins bind, stabilize, and remove lipofuscin bisretinoids from retinal pigment epithelium. Proc. Natl. Acad. Sci. USA 2014, 111, E1402–E1408. [Google Scholar] [CrossRef] [PubMed]
  28. Kageyama, A.; Oka, M.; Okada, T.; Nakamura, S.; Ueyama, T.; Saito, N.; Hearing, V.J.; Ichihashi, M.; Nishigori, C. Down-regulation of melanogenesis by phospholipase D2 through ubiquitin proteasome-mediated degradation of tyrisinase. J. Biol. Chem. 2004, 279, 27774–27780. [Google Scholar] [CrossRef] [PubMed]
  29. Ho, H.; Ganesan, A.K. The pleiotropic roles of autophagy regulators in melanogenesis. Pigment Cell Melanoma Res. 2011, 24, 595–604. [Google Scholar] [CrossRef] [PubMed]
  30. Kalie, E.; Razi, M.; Tooze, S.A. ULK1 regulates melanin levels in MNT-1 cells independently of mTORC1. PLoS ONE 2013, 8, e75313. [Google Scholar] [CrossRef] [PubMed]
  31. Murase, D.; Hachiya, A.; Takano, K.; Hicks, R.; Visscher, M.O.; Kitahara, T.; Hase, T.; Takema, Y.; Yoshimori, T. Autophagy has a significant role in determining skin color by regulating melanosome degradation in keratinocytes. J. Investig. Dermatol. 2013, 133, 2416–2424. [Google Scholar] [CrossRef] [PubMed]
  32. Sorkio, A.; Hongisto, H.; Kaarniranta, K.; Uusitalo, H.; Juuti-Uusitalo, K.; Skottman, H. Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating. Tissue Eng. Part A 2014, 20, 622–634. [Google Scholar] [CrossRef] [PubMed]
  33. Vaajasaari, H.; Ilmarinen, T.; Juuti-Uusitalo, K.; Rajala, K.; Onnela, N.; Narkilahti, S.; Suuronen, R.; Hyttinen, J.; Uusitalo, H.; Skottman, H. Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol. Vis. 2011, 17, 558–575. [Google Scholar] [PubMed]
  34. Carr, A.J.; Vugler, A.; Lawrence, J.; Chen, L.L.; Ahmado, A.; Chen, F.K.; Semo, M.; Gias, C.; da Cruz, L.; Moore, H.D.; et al. Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol. Vis. 2009, 15, 283–295. [Google Scholar] [PubMed]
  35. Klimanskaya, I.; Hipp, J.; Rezai, K.A.; West, M.; Atala, A.; Lanza, R. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004, 6, 217–245. [Google Scholar] [CrossRef] [PubMed]
  36. Hirami, Y.; Osakada, F.; Takahashi, K.; Okita, K.; Yamanaka, S.; Ikeda, H.; Yoshimura, N.; Takahashi, M. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci. Lett. 2009, 458, 126–131. [Google Scholar] [CrossRef] [PubMed]
  37. Zhu, D.; Deng, X.; Spee, C.; Sonoda, S.; Hsieh, C.L.; Barron, E.; Pera, M.; Hinton, D.R. Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival. Investig. Ophthalmol. Vis. Sci. 2011, 52, 1573–1585. [Google Scholar] [CrossRef] [PubMed]
  38. Burke, J.M. Epithelial phenotype and the RPE: Is the answer blowing in the Wnt? Prog. Retin. Eye Res. 2008, 27, 579–595. [Google Scholar] [CrossRef] [PubMed]
  39. Skottman, H. Derivation and characterization of three new human embryonic stem cell lines in Finland. In Vitro Cell. Dev. Biol. Anim. 2010, 46, 206–209. [Google Scholar] [CrossRef] [PubMed]
  40. Rimpelä, A.K.; Schmitt, M.; Latonen, S.; Hagström, M.; Antopolsky, M.; Manzanares, J.A.; Kidron, H.; Urtti, A. Drug Distribution to Retinal Pigment Epithelium: Studies on Melanin Binding. Cellular Kinetics, and Single Photon Emission Computed Tomography/Computed Tomography Imaging. Mol. Pharm. 2016, 13, 2977–2986. [Google Scholar] [CrossRef] [PubMed]
  41. Tang, B.; Cai, J.; Sun, L.; Li, Y.; Qu, J.; Snider, B.J.; Wu, S. Proteasome inhibitors activate autophagy involving inhibition of PI3K-Akt-mTOR pathway as an anti-oxidation defense in human RPE cells. PLoS ONE 2014, 9, e103364. [Google Scholar] [CrossRef] [PubMed]
  42. Ohkuma, S.; Shimizu, S.; Noto, M.; Sai, Y.; Kinoshita, K.; Tamura, H. Inhibition of cell growth by bafilomycin A1, a selective inhibitor of vacuolar H+-ATPase. In Vitro Cell. Dev. Biol. Anim. 1993, 29A, 862–866. [Google Scholar] [CrossRef] [PubMed]
  43. Huang, C.; Lin, M.Z.; Cheng, D.; Braet, F.; Pollock, C.A.; Chen, X.M. Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux. Lab. Investig. 2014, 94, 309–320. [Google Scholar] [CrossRef] [PubMed]
  44. Piippo, N.; Korkmaz, A.; Hytti, M.; Kinnunen, K.; Salminen, A.; Atalay, M.; Kaarniranta, K.; Kauppinen, A. Decline in cellular clearance systems induces inflammasome signaling in human ARPE-19 cells. Biochim. Biophys. Acta 2014, 1843, 3038–3046. [Google Scholar] [CrossRef] [PubMed]
  45. Qin, S.; De Vries, G.W. Alpha2 but not alpha1 AMP-activated protein kinase mediates oxidative stress-induced inhibition of retinal pigment epithelium cell phagocytosis of photoreceptor outer segments. J. Biol. Chem. 2008, 283, 6744–6751. [Google Scholar] [CrossRef] [PubMed]
  46. Kwon, H.J.; Rhim, J.H.; Jang, I.S.; Kim, G.E.; Park, S.C.; Yeo, E.J. Activation of AMP-activated protein kinase stimulates the nuclear localization of glyceraldehyde 3-phosphate dehydrogenase in human diploid fibroblasts. Exp. Mol. Med. 2010, 42, 254–269. [Google Scholar] [CrossRef] [PubMed]
  47. Kamao, H.; Mandai, M.; Wakamiva, S.; Ishida, J.; Goto, K.; Ono, T.; Suda, T.; Takahashi, M.; Kirvu, J. Objective evaluation of the degree of pigmentation in human induced pluripotent stem cell-derived RPE. Investig. Ophthalmol. Vis. Sci. 2014, 55, 8309–8318. [Google Scholar] [CrossRef] [PubMed]
  48. Kayatz, P.; Thumann, G.; Luther, T.T.; Jordan, J.F.; Bartz–Schmidt, K.U.; Esser, P.J.; Schraermeyer, U. Oxidation causes melanin fluorescence. Investig. Ophthalmol. Vis. Sci. 2001, 42, 241–246. [Google Scholar]
  49. Kaarniranta, K.; Sinha, D.; Blasiak, J.; Kauppinen, A.; Veréb, Z.; Salminen, A.; Boulton, M.E.; Petrovski, G. Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy 2013, 9, 973–984. [Google Scholar] [CrossRef] [PubMed]
  50. Watabe, H.; Valencia, J.C.; Yasumoto, K.; Kushimoto, T.; Ando, H.; Muller, J.; Vieira, V.D.; Mizoguchi, M.; Appella, E.; Hearing, V.J. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity. J. Biol. Chem. 2004, 279, 7971–7981. [Google Scholar] [CrossRef] [PubMed]
  51. Reinisalo, M.; Putula, J.; Mannermaa, E.; Urtti, A.; Honkakoski, P. Regulation of the human tyrosinase gene in retinal pigment epithelium cells: The significance of transcription factor orthodenticle homeobox 2 and its polymorphic binding site. Mol. Vis. 2012, 18, 38–54. [Google Scholar] [PubMed]
  52. Jeong, H.S.; Choi, H.R.; Yun, H.Y.; Baek, K.J.; Kwon, N.S.; Park, K.C.; Park, D.S. Ceramide PC102 inhibits melanin synthesis via proteasomal degradation of microphthalmia-associated transcription factor and tyrosinase. Mol. Cell. Biochem. 2013, 375, 81–87. [Google Scholar] [CrossRef] [PubMed]
  53. Jeong, H.S.; Yun, H.Y.; Baek, K.J.; Kwon, N.S.; Park, K.C.; Kim, D.S. Okadaic acid suppresses melanogenesis via proteasomal degradation of tyrosinase. Biol. Pharm. Bull. 2013, 36, 1503–1508. [Google Scholar] [CrossRef] [PubMed]
  54. Yu, A.; Malek, T.R. The proteasome regulates receptor-mediated endocytosis of interleukin-2. J. Biol. Chem. 2001, 276, 381–385. [Google Scholar] [CrossRef] [PubMed]
  55. Van Kerkhof, P.; Alves dos Santos, C.M.; Sachse, M.; Klumperman, J.; Bu, G.; Strous, G.J. Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins. Mol. Biol. Cell 2001, 12, 2556–2566. [Google Scholar] [CrossRef] [PubMed]
  56. Onnela, N.; Savolainen, V.; Juuti-Uusitalo, K.; Vaajasaari, H.; Skottman, H.; Hyttinen, J. Electric impedance of human embryonic stem cell-derived retinal pigment epithelium. Med. Biol. Eng. Comput. 2012, 50, 107–116. [Google Scholar] [CrossRef] [PubMed]
  57. Juuti-Uusitalo, K.; Delporte, C.; Grégoire, F.; Perret, J.; Huhtala, H.; Savolainen, V.; Nymark, S.; Hyttinen, J.; Uusitalo, H.; Willermain, F.; et al. Aquaporin expression and function in human pluripotent stem cell-derived retinal pigmented epithelial cells. Investig. Ophthalmol. Vis. Sci. 2013, 54, 3510–3519. [Google Scholar] [CrossRef] [PubMed]
  58. Kurz, T.; Karlsson, M.; Brunk, U.T.; Nilsson, S.E.; Frennesson, C. ARPE-19 retinal pigment epithelial cells are highly resistant to oxidative stress and exercise strict control over their lysosomal redox-active iron. Autophagy 2009, 5, 494–501. [Google Scholar] [CrossRef] [PubMed]
  59. Mitter, S.K.; Song, C.; Qi, X.; Mao, H.; Rao, H.; Akin, D.; Lewin, A.; Grant, M.; Dunn, W., Jr.; Ding, J.; et al. Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD. Autophagy 2014, 10, 1989–2005. [Google Scholar] [CrossRef] [PubMed]
  60. Decanini, A.; Nordgaard, C.L.; Feng, X.; Ferrington, D.A.; Olsen, T.W. Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. Am. J. Ophthalmol. 2007, 143, 607–615. [Google Scholar] [CrossRef] [PubMed]
  61. Kay, P.; Yang, Y.C.; Hiscott, P.; Gray, D.; Maminishkis, A.; Paraoan, L. Age-related changes of cystatin C expression and polarized secretion by retinal pigment epithelium: Potential age-related macular degeneration links. Investig. Ophthalmol. Vis. Sci. 2014, 55, 926–934. [Google Scholar] [CrossRef] [PubMed]
  62. Czarny, P.; Pawlowska, E.; Bialkowska-Warzecha, J.; Kaarniranta, K.; Blasiak, J. Autophagy in DNA damage response. Int. J. Mol. Sci. 2015, 16, 2641–2662. [Google Scholar] [CrossRef] [PubMed]
  63. Terluk, M.R.; Kapphahn, R.J.; Soukup, L.M.; Gong, H.; Gallardo, C.; Montezuma, S.R.; Ferrington, D.A. Investigating mitochondria as a target for treating age-related macular degeneration. J. Neurosci. 2015, 35, 7304–7311. [Google Scholar] [CrossRef] [PubMed]
  64. Xu, H.; Ren, D. Lysosomal physiology. Annu. Rev. Physiol. 2015, 77, 57–80. [Google Scholar] [CrossRef] [PubMed]
  65. Chen, K.G.; Leapman, R.D.; Zhang, G.; Lai, B.; Valencia, J.C.; Cardarelli, C.O.; Vieira, V.D.; Hearing, V.J.; Gottesman, M.M. Influence of melanosome dynamics on melanoma drug sensitivity. J. Natl. Cancer. Inst. 2009, 101, 1259–1271. [Google Scholar] [CrossRef] [PubMed]
  66. Koskela, A.; Reinisalo, M.; Petrovski, G.; Sinha, D.; Olmiere, C.; Karjalainen, R.; Kaarniranta, K. Nutraceutical with resveratrol and omega-3 fatty acids induces autophagy in ARPE-19 cells. Nutrients 2016, 8, 284. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Representative brightfield micrographs and gene expression of human embryonic stem cells (hESC)-derived retinal pigment epithelial (RPE) cells used in this study. (a) Reverse Transcription-Polymerase Chain Reaction gene expression analyses of mature hESC-RPE cells used for the analyses (analyzed genes on the left, water control on the right); (b) confocal micrographs after indirect immunofluorescence with RPE-specific proteins cellular retinaldehyde-binding protein (CRALBP, green) and bestrophin (red), and the nuclear label DAPI (blue, 4′,6-diamidino-2-phenylindole). Scale bar = 10 µm. On the left-hand side is the image from basal side of hESC-RPE cells with blue stained nuclei, and on the right-hand-side is the same sample from the apical side of cells. (c) A brightfield phase contrast micrograph of representative cell morphology. (d) A low resolution electron microscopy image of hESC-RPE cells cultured on inserts, showing a high degree of polarization with apical brush border and apico-lateral tight junctions, structured organization of basal extracellular matrix and a high number of pigmented granules. Scale bar = 2 µm.
Figure 1. Representative brightfield micrographs and gene expression of human embryonic stem cells (hESC)-derived retinal pigment epithelial (RPE) cells used in this study. (a) Reverse Transcription-Polymerase Chain Reaction gene expression analyses of mature hESC-RPE cells used for the analyses (analyzed genes on the left, water control on the right); (b) confocal micrographs after indirect immunofluorescence with RPE-specific proteins cellular retinaldehyde-binding protein (CRALBP, green) and bestrophin (red), and the nuclear label DAPI (blue, 4′,6-diamidino-2-phenylindole). Scale bar = 10 µm. On the left-hand side is the image from basal side of hESC-RPE cells with blue stained nuclei, and on the right-hand-side is the same sample from the apical side of cells. (c) A brightfield phase contrast micrograph of representative cell morphology. (d) A low resolution electron microscopy image of hESC-RPE cells cultured on inserts, showing a high degree of polarization with apical brush border and apico-lateral tight junctions, structured organization of basal extracellular matrix and a high number of pigmented granules. Scale bar = 2 µm.
Ijms 18 01089 g001
Figure 2. Representative transmission electron micrographs of hESC-RPE cells show that both autophagy and proteasomes regulate the amount of melanosomes after exposures to MG-132 (1 µM), AICAR (2 mM, 5-Aminoimidazole-4-carboxamide ribonucleotide) or/and bafilomycin A1 (50 nM) for 24 h. Control cells were exposed to culture medium (a). Quantification of melanosomes (b), premelanosomes (c) and autophagic vesicles (d) per 5-µm2 arbitrary selected areas per treatment. Experiments were repeated 3× independently. Proteasome inhibition by MG-132, as well as bafilomycin A1 exposure increase melanin levels in hESC-RPE cells. Simultaneous proteasome inhibition with AICAR decreases pigmentation. Melanin light absorbance at 690 nm was normalized with protein concentration of each individual sample. Results are means ± standard deviation (SD) relative to the control sample from two independent experiment. The melanin level set at 100% corresponds to the amount of 0.452 ± 0.07 µg melanin/µg protein in the sample (e). An example of the double membrane autophagosome around melanosomes in hESC- RPE cells treated with MG-132 and AICAR (f). ** p < 0.01, Mann–Whitney U. The arrow indicates a double membrane autophagosome, the asterisk a single membrane autophagolysosome and Roman numerals (I–IV) different stages of circuited melanosomes. Double membrane and/or degradative material inside of vesicles were criteria for phagosome calculation. Organelles were manually calculated from transmission electron microscopy (TEM) micrographs. Typical micrographs were selected for analysis. The TEM photographer knew the sample codes, but examiners were masked during organelle analysis.
Figure 2. Representative transmission electron micrographs of hESC-RPE cells show that both autophagy and proteasomes regulate the amount of melanosomes after exposures to MG-132 (1 µM), AICAR (2 mM, 5-Aminoimidazole-4-carboxamide ribonucleotide) or/and bafilomycin A1 (50 nM) for 24 h. Control cells were exposed to culture medium (a). Quantification of melanosomes (b), premelanosomes (c) and autophagic vesicles (d) per 5-µm2 arbitrary selected areas per treatment. Experiments were repeated 3× independently. Proteasome inhibition by MG-132, as well as bafilomycin A1 exposure increase melanin levels in hESC-RPE cells. Simultaneous proteasome inhibition with AICAR decreases pigmentation. Melanin light absorbance at 690 nm was normalized with protein concentration of each individual sample. Results are means ± standard deviation (SD) relative to the control sample from two independent experiment. The melanin level set at 100% corresponds to the amount of 0.452 ± 0.07 µg melanin/µg protein in the sample (e). An example of the double membrane autophagosome around melanosomes in hESC- RPE cells treated with MG-132 and AICAR (f). ** p < 0.01, Mann–Whitney U. The arrow indicates a double membrane autophagosome, the asterisk a single membrane autophagolysosome and Roman numerals (I–IV) different stages of circuited melanosomes. Double membrane and/or degradative material inside of vesicles were criteria for phagosome calculation. Organelles were manually calculated from transmission electron microscopy (TEM) micrographs. Typical micrographs were selected for analysis. The TEM photographer knew the sample codes, but examiners were masked during organelle analysis.
Ijms 18 01089 g002
Figure 3. Representative Western blotting analysis and pH-sensitive Green Fluorescent Protein (GFP)-mCherry-LC3A vector shows that AICAR decreases protein levels of LC3–II/I (microtubule-associated protein 1A/1B-light chain 3) (a,b) and p62 (c) and induced autophagy flux (df) during proteasome inhibition. Proteins in the total homogenates of hESC-RPE cells after exposures to MG-132 (1 µM), AICAR (2 mM), or/and bafilomycin A1 (50 nM) for 24 h, or medium in control cells were analyzed using Western blot, with α-tubulin as a loading control. Statistical analysis was performed by ANOVA followed by Tukey’s test for multiple comparison, * p < 0.05, ** p < 0.01, *** p < 0.001. Representative confocal microscopy images (n = 3–4 biological replicates and in each 1–4 images/sample) of mature hESC-RPE cells 24 h after transfections with green fluorescent protein (GFP)-mCherry-LC3A, where AICAR treatment has induced autophagy flux with proteasome inhibition. (d) From left to right are: the control (CTRL), i.e., transfected sample without other treatments; transfected and treated with MG-132 (1 μM); transfected and treated with MG-132 and AICAR (2 mM); transfected and treated with AICAR (2 mM); transfected and treated with bafilomycin A1 (50 nM); transfected and treated with MG-132 (1 μM) and bafilomycin A1 (50 nM); transfected and treated with AICAR (2 mM) and bafilomycin A1 (50 nM) for 3 h or 24 h. Scale bar = 10 µm. (e) The area of green, yellow (autophagosomes) and red (autolysosomes) of the confocal images were analyzed with Image J by dividing pixels of red channel with the pixels of green channel; the output was re-scaled from 0–2 and presented with the UnionJack color scale (0 = black, white = 1 and red = 2). (f) In order to visualize the output better, the results are shown as histograms.
Figure 3. Representative Western blotting analysis and pH-sensitive Green Fluorescent Protein (GFP)-mCherry-LC3A vector shows that AICAR decreases protein levels of LC3–II/I (microtubule-associated protein 1A/1B-light chain 3) (a,b) and p62 (c) and induced autophagy flux (df) during proteasome inhibition. Proteins in the total homogenates of hESC-RPE cells after exposures to MG-132 (1 µM), AICAR (2 mM), or/and bafilomycin A1 (50 nM) for 24 h, or medium in control cells were analyzed using Western blot, with α-tubulin as a loading control. Statistical analysis was performed by ANOVA followed by Tukey’s test for multiple comparison, * p < 0.05, ** p < 0.01, *** p < 0.001. Representative confocal microscopy images (n = 3–4 biological replicates and in each 1–4 images/sample) of mature hESC-RPE cells 24 h after transfections with green fluorescent protein (GFP)-mCherry-LC3A, where AICAR treatment has induced autophagy flux with proteasome inhibition. (d) From left to right are: the control (CTRL), i.e., transfected sample without other treatments; transfected and treated with MG-132 (1 μM); transfected and treated with MG-132 and AICAR (2 mM); transfected and treated with AICAR (2 mM); transfected and treated with bafilomycin A1 (50 nM); transfected and treated with MG-132 (1 μM) and bafilomycin A1 (50 nM); transfected and treated with AICAR (2 mM) and bafilomycin A1 (50 nM) for 3 h or 24 h. Scale bar = 10 µm. (e) The area of green, yellow (autophagosomes) and red (autolysosomes) of the confocal images were analyzed with Image J by dividing pixels of red channel with the pixels of green channel; the output was re-scaled from 0–2 and presented with the UnionJack color scale (0 = black, white = 1 and red = 2). (f) In order to visualize the output better, the results are shown as histograms.
Ijms 18 01089 g003aIjms 18 01089 g003b
Figure 4. Representative micrograph images of the viability assay of mature hESC-RPE cells 24 h after exposures to MG-132 (1 µM), AICAR (2 mM) or/and bafilomycin A1 (50 nM) for 24 h compared to the control. Scale bar 20 µm. Underneath the micrographs are graphs where the intensity of calcein has been analyzed with Image J software and the number of dead cells (red nuclei), both from five fields of view. Statistical analysis was performed by two-tailed Mann–Whitney U against the control, ** p < 0.01, *** p < 0.001.
Figure 4. Representative micrograph images of the viability assay of mature hESC-RPE cells 24 h after exposures to MG-132 (1 µM), AICAR (2 mM) or/and bafilomycin A1 (50 nM) for 24 h compared to the control. Scale bar 20 µm. Underneath the micrographs are graphs where the intensity of calcein has been analyzed with Image J software and the number of dead cells (red nuclei), both from five fields of view. Statistical analysis was performed by two-tailed Mann–Whitney U against the control, ** p < 0.01, *** p < 0.001.
Ijms 18 01089 g004
Table 1. Culture periods of cell samples.
Table 1. Culture periods of cell samples.
AnalysisAdherent Culture Period (SD)Entire Culture Period (SD)
RT-PCR (n = 4)d104 (83–112)d230 (235–244)
TEM (n = 4)d127 (36–194)d279 (158–404)
WB (n = 8)d100 (51–194)d299 (244–383)
IF (n = 79)d83 (36–112)d277 (197–356)
Live-dead (n = 2)d83 (36–112)d277 (197–356)
TEM: Transmission Electron Microscopy; WB: Western blot; IF: immunofluorescence.
Table 2. Antibodies used in immunofluorescence labelling.
Table 2. Antibodies used in immunofluorescence labelling.
Antibody NameAbbreviationPrimary/SecondaryHostDilutionCatManufacturer
Anti-cellular retinaldehyde-binding proteinCRALBPprimarymouse monoclonal1:1000ab15051Abcam, Cambridge, UK
Rabbit anti-bestrophinBestrophinprimaryrabbit monoclonal1:500ab14928Abcam
Anti-mouse IgG Alexa Fluor 488-secondary polyclonaldonkey1:800A21202Molecular Probes, Life Technologies, Paisley, UK
Anti-rabbit IgG Alexa Fluor 568-secondary polyclonalgoat1:800A11011Molecular Probes, Life Technologies
Table 3. Reverse-transcriptase-PCR primer sequences and used annealing temperatures.
Table 3. Reverse-transcriptase-PCR primer sequences and used annealing temperatures.
GenePrimer Sequences (5′ > 3′)Tm
ForwardReverse
GAPDHGTT CGA CAG TCA GCC GCA TCGGA ATT TGC CAT GGG TGG A55
OCT 3/4CGTGAAGCTGGAGAAGGAGAAGCTGAAGGGCCGCAGCTTACACATGTTC55
PAX6AAC AGA CAC AGC CCT CAC AAA CACGG GAA CTT GAA CTG GAA CTG AC60
MITFAAG TCC TGA GCT TGC CAT GTGGC AGA CCT TGG TTT CCA TA52
BestrophinGAATTTGCAGGTGTCCCTGTATCAGGAGGACGAGGAGGAT60
RPE65TCC CCA ATA CAA CTG CCA CTCAC CACC ACA CTC AGA ACT A52
Tm: Annealing temperature.

Share and Cite

MDPI and ACS Style

Juuti-Uusitalo, K.; Koskela, A.; Kivinen, N.; Viiri, J.; Hyttinen, J.M.T.; Reinisalo, M.; Koistinen, A.; Uusitalo, H.; Sinha, D.; Skottman, H.; et al. Autophagy Regulates Proteasome Inhibitor-Induced Pigmentation in Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells. Int. J. Mol. Sci. 2017, 18, 1089. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051089

AMA Style

Juuti-Uusitalo K, Koskela A, Kivinen N, Viiri J, Hyttinen JMT, Reinisalo M, Koistinen A, Uusitalo H, Sinha D, Skottman H, et al. Autophagy Regulates Proteasome Inhibitor-Induced Pigmentation in Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells. International Journal of Molecular Sciences. 2017; 18(5):1089. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051089

Chicago/Turabian Style

Juuti-Uusitalo, Kati, Ali Koskela, Niko Kivinen, Johanna Viiri, Juha M. T. Hyttinen, Mika Reinisalo, Arto Koistinen, Hannu Uusitalo, Debasish Sinha, Heli Skottman, and et al. 2017. "Autophagy Regulates Proteasome Inhibitor-Induced Pigmentation in Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells" International Journal of Molecular Sciences 18, no. 5: 1089. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051089

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop